PURE - PURE Bioscience, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,8311,289729
Cost of Revenue760441285
Gross Profit1,071848444
Operating Expenses
Research Development779927790
Selling General and Administrative6,3006,9787,294
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-6,008-7,057-7,640
Income from Continuing Operations
Total Other Income/Expenses Net-250-7,30421
Earnings Before Interest and Taxes-6,258-14,361-7,619
Interest Expense5108
Income Before Tax-6,263-14,371-7,627
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-6,263-14,371-7,627
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-6,263-14,371-7,627
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-6,263-14,371-7,627